Metacrine Reports Third-Quarter 2022 Results
14 nov. 2022 16h38 HE
|
Metacrine, Inc.
SAN DIEGO, Nov. 14, 2022 (GLOBE NEWSWIRE) -- Metacrine, Inc. (NASDAQ:MTCR), a clinical-stage biopharmaceutical company developing differentiated therapies for patients with gastrointestinal...
Metacrine Reports First-Quarter 2022 Results
12 mai 2022 16h05 HE
|
Metacrine, Inc.
SAN DIEGO, May 12, 2022 (GLOBE NEWSWIRE) -- Metacrine, Inc. (NASDAQ:MTCR), a clinical-stage biopharmaceutical company pioneering differentiated therapies for patients with gastrointestinal diseases,...
Metacrine to Present at 2021 RBC Global Healthcare Conference
11 mai 2021 08h05 HE
|
Metacrine, Inc.
SAN DIEGO, May 11, 2021 (GLOBE NEWSWIRE) -- Metacrine, Inc. (NASDAQ:MTCR), a clinical-stage biopharmaceutical company pioneering differentiated therapies for patients with liver and gastrointestinal...